In our study, we investigated transient global cerebral ischemia (TGCI)-induced changes in spatial memory and motor activity together with apoptotic, oxidant, and NO/NOS signaling parameters in rats and the effects of treatment of animals with ghrelin. The TGCI-induced deficiencies of spatial memory and motor activity in the Y-maze and open field tests were attenuated by ghrelin treatment. Furthermore, ghrelin administration lowered the levels of caspase-3 and iNOS elevated by TGCI in the hippocampus. Thus, we conclude that ghrelin exerts a neuroprotective action against hippocampal TGCI injury via influencing apoptotic, oxidant, and/or NO/NOS pathways. If the underlying mechanisms of action of this agent are fully clarified, ghrelin might be a candidate drug for treatment of TGCI-induced memory impairments.
INTRODUCTION
Transient global cerebral ischemia (TGCI), usually stemming from severe arrhythmia, cardiac arrest, or hemorrhagic shock, is a leading cause of death and adult disability in industrialized countries, and the respective treatment options are limited [1] . Even though several agents have been found to be neuroprotective in animal models, most of them have failed to be transferred from the laboratory to the clinic [2] . Thus, there is an urgent medical need to develop novel therapies for TGCI. Neurophysiological dysfunctions, including learning and memory disabilities, are major outcomes of TGCI mediated through delayed neuronal death (DND) starting 2-3 days after reperfusion mostly in the cerebral cortex and hippocampus [1] . The latter is the brain structure greatly vulnerable to neurodegenerative effects of TGCI in humans [3] [4] [5] and animals [6] . Hence, behavioral and cognitive disturbances, particularly within the learning and memory domains, are the most apparent symptoms of TGCI, and loss of spatial learning and memory abilities are the parameters usually described in rodent models of TGCI [7] .
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apoptosis, the programmed cell death essential for eliminating damaged or aged cells and maintaining tissue integrity [8] . The specific morphological changes associated with apoptosis are cell shrinkage, chromatin condensation, internucleosomal deoxyribonucleic acid (DNA) fragmentation, and formation of apoptotic bodies [9] . The majority of morphological and biochemical changes stem from various enzymatic reactions most of which are catalyzed by caspases playing essential roles during apoptotic cell death [10] . There are two types of caspases: initiator caspases (caspases 8, 10, 9, and 2) and effector caspases (caspases 3, 7, and 6); the latter are activated by initiator ones [11] . Among all members of the caspase family, caspase-3 is the most abundant in the brain, and its activation is considerably implicated in ischemic cell death [12] .
Oxidative stress, stemming from distortion of the equilibrium between production and scavenging of free radicals, is one of the most important pathological mechanisms leading to DND following TGCI [13] . Beside oxidative stress, nitrosative stress is another pathological mechanism significantly contributing to DND induced by excessive nitric oxide (NO) production through nitric oxide synthases (NOSs) [14] . The role of NO in pathogenesis of ischemic brain damage is controversial. Some evidence has been accumulated that NO plays both neurotoxic and neuroprotective roles during the process of cerebral ischemia and reperfusion [15, 16] .
Moreover, modulation of different NOSs, such as neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS), have been shown to produce a variety of outcomes in ischemic brain injury [17] . Neuronal NOS and especially iNOS activities have been proposed to be detrimental to the ischemic brain [18] [19] [20] . Hence, agents preventing iNOS overexpression, such as ghrelin, might be potential therapeutic means in TGCI [21] .
Ghrelin is a 28-amino acid peptide esterified with octanoic acid on serine 3. It is mainly released from oxyntic cells of the stomach mucosa. The ability of ghrelin to stimulate growth hormone (GH) release by activating GH secretagogue receptors (GHSRs 1a) in the pituitary was discovered in [22] . Ghrelin has several other peripheral actions, including direct effects on the systemic vascular resistance, gastric secretion, stomach motility, sleep, learning, and memory [23] [24] [25] [26] [27] . Additionally, recent studies highlighted that ghrelin also exerts neuroprotective actions in ischemic models of stroke both in vivo and in vitro [28, 29] .
Therefore, in this study we investigated the effects of ghrelin on TGCI-induced hippocampal damage and memory impairments together with its relation to apoptotic, oxidant, and NO/NOS signaling in rats.
METHODS
Animals. Forty-five adult male Wistar rats weighing 300-350 g were used for the experiments. The animals were housed at room temperature (23 ± ± 1°C) and 12-h day/night cycle and supplied with standard laboratory chow and water ad libitum.
Experimental Procedures. Rats were randomly divided into control (C), ischemia/reperfusion (IR), and ischemia/reperfusion+ghrelin (IR+G) groups (n = 15 in each group). Rats of the C group underwent sham surgery, i.e., without vessel occlusion, and received vehicle (saline) via daily i.p. injections after operation for 3 days. The IR-group rats were exposed to global cerebral ischemia/reperfusion and received daily saline i.p. injections for 3 days after reperfusion. Rats of the IR+G group underwent global cerebral ischemia/reperfusion surgery and received daily ghrelin injections (80 µg/kg·day, i.p.) as treatment for 3 post-reperfusion days [28] .
The Y-maze and open field tests were carried out on the first and second post-reperfusion days. The Y-maze test was followed by the open field test with a 1-h-long time interval. On the third day after reperfusion, rats were perfused transcardially with heparinized saline under deep urethane anesthesia; the brains were removed immediately, and the extracted hippocampi were stored at -80°C for biochemical assays.
Drug Preparation. Rat ghrelin (purchased from GenScript Inc., USA) was dissolved in distilled water (1 mg/ml) and stored at -20°C until the time of preparation for administration. Immediately before administration by i.p. injection, ghrelin was diluted again with 0.9% saline to the final concentration of 0.1 mg/ml. [30] .
Global Cerebral Ischemia/Reperfusion. Global ischemia was induced by four-vessel occlusion (4-VO), as previously described by Pulsinelli and Brierley [31] , with some modification. In brief [32] , an incision was made 2.5 cm dorsal to the cervical midline under deep ketamine/xylazine anesthesia (100/10 mg/kg, i.p.), and vertebral arteries were irreversibly occluded by electrocoagulation through the alar foraminae of the 1st cervical vertebra. Immediately after electrocoagulation, bitemporal subdermal EEG needle electrodes were placed in reference to a frontal subdermal electrode, and an incision was made 2.5 cm with respect to the ventral cervical midline. After a baseline EEG level had been estimated, both common carotid arteries were exposed and occluded with micro aneurysm clips for 8 min, and this was followed by reperfusion. The experiments were performed only if the animals showed a completely flat bitemporal EEG during the carotid artery occlusion. Shamoperated rats underwent all procedures except the latter bilateral common carotid artery occlusion. A heating pad was applied in order to maintain the rats' body temperature at 37 ± 0.5°C. Each group of animals received the same degree of surgical manipulations and the same recovery paradigms, to minimize variations that could be induced by surgical procedures.
Behavioral Tests. The Y-maze Test. Spatial memory was evaluated using a Y-maze test paradigm [33] at 24 and 48 h after ischemia. The maze was constructed of gray Plexiglas and consisted of a stem arm (42 cm long) and two identical arms (37 cm long, diverging at a 45° angle from the stem arm) surrounded by extra-maze cues of varying shapes and sizes. During 15-min information trials, rats were free to explore the stem arm and one of the second arms, but access to the third arm (novel arm) was blocked by a plastic partition. Following the initial information trial, rats were returned to their home cages for a 4-h-long interval. After the delay, each rat re-entered the Y-maze in the stem arm and was allowed to explore all three arms during a 5-min retention trial. Retention trials were video-recorded (Noldus Ethovision XT System, The Netherlands) for scoring the arm entries. Arm entry was defined as all four paws crossing the dividing line between the arm and the central area. The maze was cleaned thoroughly with 70% ethanol and air-dried after each trial to remove olfactory cues. Spatial memory was indicated by increased entries into the novel arm during the retention trial.
Open Field. Exploratory behavior was tested in an open field constructed of black Plexiglas (100 cm × 100 cm × 45 cm) arena. Each rat was placed in the center of the open field and allowed a single exploration trial of 3 min. The floor and walls were cleaned thoroughly with 70% ethanol and allowed to air-dry after each trial, to remove olfactory cues. The activity was monitored by a video camera and recorded for later analysis. The field was virtually divided into 16 equal-sized squares. Entry into a square was scored when the rat crossed the borders of a designated square with all four paws. Exploratory behavior and locomotor activity were evaluated by calculating the total number of squares entered and total distance moved, respectively [33] .
Biochemical Assays. Estimation of the Total Oxidant Status (TOS). Total oxidant status was measured by a commercially available TOS assay kit (cat. No. RL0024, Rel Assay Diagnostics, Turkey). The assay was calibrated with hydrogen peroxide, and the results are expressed below as µmol H 2 O 2 /g protein.
NO Metabolites (Nitrite+Nitrate). The nitrite+nitrate level was measured using a commercial nitrate/nitrite colorimetric assay kit (cat. No. 78001; Cayman Chemical, USA) in accordance with the manufacturer's instructions. Briefly, the hippocampi were dissected on ice, homogenized in PBS, and centrifuged at 10,000g for 20 min. The supernatant was centrifuged at 100,000g for 30 min and then filtered through a 10-kDa molecular mass cutoff filter. The nitrate+nitrite level was measured in duplicate on 96-well plastic microplates. The absorbance was read at 570/620 nm using a multiwell microplate reader.
Immunohistochemistry of iNOS, nNOS, and Caspase-3. Under deep anesthesia, animals were perfused transcardially with 200 ml of saline followed by 300 ml of 4% paraformaldehyde solution. Brains were removed and postfixed in the same paraformaldehyde solution for 24 h and then embedded in paraffin. Five-μm-thick coronal sections were cut, collected on poly-L-lysinecoated slides (Sigma-Aldrich, USA), and incubated overnight at 56°C. For immunohistochemical assays, brain sections were deparaffinized in xylene and rehydrated in a graded ethanol series. Sections were then treated with 10 mM citrate buffer (pH 6.0) for 5 min twice in a microwave oven and left to cool down for 20 min. After three washes in phosphatebuffered saline (PBS), sections were incubated in a universal blocking reagent (BioGenex, USA) for 7 min at room temperature in order to block nonspecific binding. Subsequently, sections were incubated overnight at 4°C with rabbit anti-iNOS (1:200; ab3523), rabbit anti-nNOS (1:100; ab76067, both from Abcam, USA), and cleaved caspase-3 (1:100, Cell Signaling No. 9661) primary antibodies. After several washes in PBS, sections were incubated with goat anti-rabbit-biotin secondary antibody (1:400; Vector Labs., USA) for 60 min at room temperature and rinsed with PBS. Visualization was performed via a streptavidin-peroxidase complex (Dako, USA) and diaminobenzidine (BioGenex, USA). Sections were counterstained with Mayer's hematoxylin, mounted with Kaisers Glycerol-Gelatin (Merck, Cat. No. 1.09242.0100, Germany), and examined using a light microscope.
Statistical Analysis. The obtained numerical data were treated by SPSS (version 18.0) software package for Windows. Since the numbers of entries to the novel arm in the Y-maze did not follow a normal distribution, and their variance did not fit the assumption of homoscedasticity, the relevant data are expressed as medians (min-max), while the remaining results are expressed as means ± ± s.e.m. All variables were analyzed with the nonparametric Kruskal-Wallis test, and all pairwise multiple comparisons were performed by the MannWhitney U test; differences with P values smaller than 0.05 were considered significant.
RESULTS

TGCI-Induced Spatial Memory Changes and
Effects of Ghrelin Treatment. Table 1 shows the number of entries to the novel arm and total distance moved in the Y-maze. The number of entries to the novel arm and total distance moved were smaller in the IR group with respect to the C group on both post-reperfusion day 1 and day 2. On day 1, ghrelin administration resulted in an increase in the number of entries to the novel arm, as compared to the IR group; however, on day 2 no significant effect of the drug was observed. Ghrelin treatment did not cause significant changes in the total distance moved in the IR+G group either on day 1 or on day 2.
TGCI-Induced Motor Activity Changes and Effects of Ghrelin Treatment. The number of squares entered and total distance moved in the open field test for all experimental groups are shown in Table 2 . Both these indices were significantly lower in the IR group compared to the C group on both day 1 and day 2. Ghrelin administration significantly increased both the number of squares entered and the total distance moved on day 1 and day 2 in the IR+G group with respect to the IR group.
Hippocampal TOS Levels. Total oxidant status results are illustrated in Fig. 1 (Fig. 3) . The immunoreactivity with respect to iNOS in the hippocampus was significantly higher in the IR group (Fig. 3B) with respect to the C group (Fig.  3A) . Ghrelin treatment noticeably decreased the number of iNOS-positive neurons in the IR+G group (Fig. 3C) as compared with the IR group.
Hippocampal nNOS expression. Hippocampal nNOS immunoreactivity (brown staining) was also evaluated by immunohistochemistry (Fig. 4) . The nNOS immunostaining was mostly observed in the hippocampi in the IR group (Fig. 4B) . There was weak nNOS immunolabelling found in the IR+G group (Fig. 4C) . No significant difference was observed between the nNOS immunoreactivity in the C and IR+G groups.
Hippocampal Cleaved Caspase-3 Expression. Immunohistochemical analysis of the hippocampal region demonstrated that the caspase-3 level was elevated after TGCI in the IR group (Fig. 5B) . Ghrelin caused a strong decrease in the caspase-3 level in the IR+G group (Fig. 5C ) compared to the above-mentioned IR group. No caspase-3 expression was observed in the C group (Fig. 5A) .
DISCUSSION
Even though TGCI is one of the leading causes of human death and disability across the world [34] , there are still very limited therapeutic options [35] . Hence, this dramatic disorder remains a demanding clinical problem for which the development of new therapies is necessary.
Patients who experienced TGCI usually suffer from various degrees of memory impairment and learning dysfunction due, to a significant extent, to the hippocampal damage [36, 37] . Circulating ghrelin in the hippocampus was shown to cross the blood-brain barrier, to enhance long-term potentiation (LTP), and to improve spatial memory [38] . Based on these results, we investigated the possible therapeutic effects of ghrelin on TGCIinduced deterioration of spatial memory and exploratory behavior in rats. Our data suggested that ghrelin has a clear positive effect on spatial memory impairment induced by TGCI on the first day after reperfusion. However, its protective effect mostly vanished on the second post-reperfusion day. This situation might occur due to an insufficient dose of ghrelin used in our experiments. In other words, as hippocampus-dependent memory impairment progresses within the reperfusion period, the administered amount of ghrelin was not sufficient to overcome the damage within later segments of the post-reperfusion period. In addition, ghrelin administration resulted in enhancement of motor activity that was previously deteriorated by TGCI. The effect of ghrelin on motor activity was observed not only on the first day, but also on the second day after reperfusion. Although the memoryand motor activity-enhancing effects of ghrelin have been reported in the literature, the underlying mechanism is not fully understood yet [39] . Therefore, further studies are required to clarify the mechanisms of action of this agent.
The hippocampus is selectively vulnerable to TGCI; hippocampal degeneration begins to be observed histologically 2-3 days after ischemia [6] . With reference to these crucial findings, we evaluated apoptotic changes in the hippocampus 3 days after ischemia via caspase-3 immunostaining in order to see is there any correlation between behavioral and apoptotic changes. Ultimately, higher caspase-3 immunoreactivity was observed in the IR group with respect to the C group. Along the same lines with our findings, Liu et al. [40] showed that 8-min-long TGCI resulted in dramatic cell loss in the hippocampus 3 days after ischemia. Pooling our behavioral and histological results together, we postulate that TGCI causes memory impairment by inducing DND via an apoptotic pathway in the hippocampus.
At present, a few investigations are being carried out in order to suggest neuroprotective therapies to overcome hippocampal degeneration caused by TGCI. Recent studies highlighted the neuroprotective actions of ghrelin in ischemic models of stroke, both in vivo and in vitro. In vivo rat IR models showed that ghrelin provides significant neuroprotection in the forebrain by reducing infarct volume and cell death [28, 29] . We also observed that ghrelin treatment (80 µg/kg) lowered the caspase-3 immunoreactivity in the IR+G group. Together with behavioral changes, it might be suggested that ghrelin attenuates TGCIinduced memory impairment by affecting an apoptotic pathway. In that respect, ghrelin might be considered a potential therapeutic mean with respect to hippocampal TGCI injury. Therefore, further research should be conducted in order to elucidate the details of molecular pathway(s) mediating the anti-apoptotic action of ghrelin.
Oxidative stress, the consequence of free radical overproduction, is a well-identified pathophysiological mechanism of IR injury [41, 42] . With the beginning of reperfusion, abrupt oxygenation of the brain tissue causes excessive production of oxygen radicals intensely oxidizing membrane lipids, cellular proteins, and DNA, thus leading to intensification of apoptosis [43] . In our study, similar to previous reports, we also observed an elevation of TOS in the hippocampus after TGCI. We, however, found that ghrelin administration did not effectively lower the TOS level in the IR+G group. At the same time, other authors [44, 45] suggested that ghrelin expression affects oxidative stress in different cell types. Our negative result might be related to a dose of ghrelin insufficient to reduce oxidative stress significantly. In order to clarify the pathways mediating the possible effects of ghrelin, protein levels, mRNA expression, and activities of both oxidant and antioxidant enzymes should be investigated in a dose-dependent manner in further studies.
Nitric oxide, a highly reactive signaling molecule in the CNS is one of the free radicals elevated during ischemic brain injury [46] . Being a gaseous chemical messenger, NO plays key roles in neuron-to-neuron changes in the hippocampal NOS levels.
Nitric oxide is a "double-edged sword" in IR injury; in addition to the amount, the source of NO is another crucial factor determining its effects in cerebral ischemia. Nitric oxide produced by eNOS has been suggested to exert beneficial effects during cerebral ischemia-reperfusion; nNOS and, especially, iNOS are considered to be detrimental since they produce a considerable amount of NO resulting in DNA damage [53] . We found that iNOS and nNOS immunoreactivities were raised in the hippocampus after TGCI. Therefore, the high nitrite+nitrate level in the IR group can be attributed to increases in the iNOS and nNOS levels. The latter effect (increase of iNOS and nNOS expressions) was reported by other authors in models of focal cerebral ischemia in mice and rats [54] [55] [56] . Ghrelin treatment, on the other hand, lowered iNOS and nNOS immunoreactivities in the IR+G group, as compared with the IR group. Hence, we can conclude that the lower nitrite+nitrate level was a consequence of decreases in iNOS and nNOS expressions in the IR+G group with respect to the IR group. Indeed, ghrelin has in several reports been suggested to modulate NO/NOS signaling [57, 58] . Brzozowski et al. [58] showed that ghrelin inhibits expression of iNOS mRNA under stress conditions and upregulates constitutive NOS (eNOS and nNOS) mRNA. Additionally, Carlini et al. [57] suggested that ghrelin affects memory consolidation and reduces the LTP threshold through the NO/NOS signaling pathway. Similarly to previous studies, the observed effect of ghrelin on TGCI-induced memory changes in our study might also to a noticeable extent be attributed to NO/NOS pathway modulation.
Thus, we examined the effects of ghrelin on TGCIinduced behavioral impairment and accompanying changes in the apoptotic, oxidant, and NO/ NOS pathways in the rat hippocampus. Pooling results together, we believe that ghrelin might be a candidate drug for treatment of TGCI-induced memory impairment provided that the underlying mechanisms are fully clarified in further studies. communication, synaptic plasticity, and memory formation [47, 48] . Unless existing in physiological low concentrations, NO might affect tissues through toxic actions mediated mostly by the peroxynitrite radical (ONOO-) [49] . Although not being fully understood yet, the mechanism underlying TGCI injury is suggested to involve NO signaling due to the induction of excessive NO production [50, 51] . Together with NO, the levels of its metabolites, such as nitrites and nitrates, are also elevated following TGCI [52] . In our study, a marker of NO production, the nitrite+nitrate level, was elevated in the hippocampus after TGCI. We observed that ghrelin administration lowered this level in the hippocampi in the IR+G group, but the effect did not reach the significance level. Alterations in the nitrite+nitrate concentration might be explained by
